vs
Astrana Health, Inc.(ASTH)与Crown Castle(CCI)财务数据对比。点击上方公司名可切换其他公司
Crown Castle的季度营收约是Astrana Health, Inc.的1.1倍($1.0B vs $950.5M),Crown Castle净利率更高(77.2% vs 0.7%,领先76.5%),Astrana Health, Inc.同比增速更快(42.9% vs -4.8%),Astrana Health, Inc.自由现金流更多($-6.0M vs $-43.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs -4.5%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
Crown Castle Inc.是总部位于美国得克萨斯州休斯敦的房地产投资信托企业,同时是美国共享通信基础设施服务商,在全球设有100个办事处,旗下拥有超4万座信号塔、约8.5万英里光纤线路,为小基站及光纤系统提供网络支撑。
ASTH vs CCI — 直观对比
营收规模更大
CCI
是对方的1.1倍
$950.5M
营收增速更快
ASTH
高出47.7%
-4.8%
净利率更高
CCI
高出76.5%
0.7%
自由现金流更多
ASTH
多$37.0M
$-43.0M
两年增速更快
ASTH
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $1.0B |
| 净利润 | $6.6M | $780.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 77.2% |
| 营收同比 | 42.9% | -4.8% |
| 净利润同比 | 184.4% | 76.0% |
| 每股收益(稀释后) | $0.12 | $1.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
CCI
| Q1 26 | — | $1.0B | ||
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $1.1B | ||
| Q2 25 | $654.8M | $1.1B | ||
| Q1 25 | $620.4M | $1.1B | ||
| Q4 24 | $665.2M | $1.1B | ||
| Q3 24 | $478.7M | $1.1B | ||
| Q2 24 | $486.3M | $1.1B |
净利润
ASTH
CCI
| Q1 26 | — | $780.0M | ||
| Q4 25 | $6.6M | $294.0M | ||
| Q3 25 | $373.0K | $323.0M | ||
| Q2 25 | $9.4M | $291.0M | ||
| Q1 25 | $6.7M | $-464.0M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $303.0M | ||
| Q2 24 | $19.2M | $251.0M |
毛利率
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | — | 97.4% | ||
| Q3 25 | — | 97.2% | ||
| Q2 25 | — | 97.5% | ||
| Q1 25 | — | 97.4% | ||
| Q4 24 | — | 97.7% | ||
| Q3 24 | — | 97.6% | ||
| Q2 24 | — | 97.7% |
营业利润率
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 48.8% | ||
| Q3 25 | 2.0% | 49.0% | ||
| Q2 25 | 3.1% | 47.7% | ||
| Q1 25 | 3.3% | 49.1% | ||
| Q4 24 | 0.1% | 51.0% | ||
| Q3 24 | 5.9% | 47.5% | ||
| Q2 24 | 6.2% | 44.7% |
净利率
ASTH
CCI
| Q1 26 | — | 77.2% | ||
| Q4 25 | 0.7% | 27.5% | ||
| Q3 25 | 0.0% | 30.1% | ||
| Q2 25 | 1.4% | 27.5% | ||
| Q1 25 | 1.1% | -43.7% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 27.1% | ||
| Q2 24 | 3.9% | 22.7% |
每股收益(稀释后)
ASTH
CCI
| Q1 26 | — | $1.80 | ||
| Q4 25 | $0.12 | $0.67 | ||
| Q3 25 | $0.01 | $0.74 | ||
| Q2 25 | $0.19 | $0.67 | ||
| Q1 25 | $0.14 | $-1.07 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | $0.70 | ||
| Q2 24 | $0.40 | $0.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $55.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | — |
| 总资产 | $2.2B | $31.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
CCI
| Q1 26 | — | $55.0K | ||
| Q4 25 | $429.5M | $99.0M | ||
| Q3 25 | $463.4M | $57.0M | ||
| Q2 25 | $342.1M | $94.0M | ||
| Q1 25 | $260.9M | $60.0M | ||
| Q4 24 | $290.8M | $100.0M | ||
| Q3 24 | $350.3M | $194.0M | ||
| Q2 24 | $327.7M | $155.0M |
总债务
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | — | $21.6B | ||
| Q3 25 | — | $21.6B | ||
| Q2 25 | — | $22.0B | ||
| Q1 25 | — | $22.9B | ||
| Q4 24 | — | $23.5B | ||
| Q3 24 | — | $23.5B | ||
| Q2 24 | — | $22.9B |
股东权益
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $-1.6B | ||
| Q3 25 | $775.5M | $-1.5B | ||
| Q2 25 | $765.5M | $-1.4B | ||
| Q1 25 | $745.4M | $-1.3B | ||
| Q4 24 | $712.7M | $-133.0M | ||
| Q3 24 | $704.6M | $5.3B | ||
| Q2 24 | $678.9M | $5.7B |
总资产
ASTH
CCI
| Q1 26 | — | $31.4M | ||
| Q4 25 | $2.2B | $31.5B | ||
| Q3 25 | $2.2B | $31.5B | ||
| Q2 25 | $1.4B | $31.6B | ||
| Q1 25 | $1.3B | $31.8B | ||
| Q4 24 | $1.4B | $32.7B | ||
| Q3 24 | $1.3B | $38.0B | ||
| Q2 24 | $1.3B | $38.2B |
负债/权益比
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 4.43× | ||
| Q2 24 | — | 4.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-43.0M |
| 自由现金流率自由现金流/营收 | -0.6% | -4.3% |
| 资本支出强度资本支出/营收 | 0.3% | 14.9% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $4.3B |
8季度趋势,按日历期对齐
经营现金流
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $3.1B | ||
| Q3 25 | $10.0M | $714.0M | ||
| Q2 25 | $90.9M | $832.0M | ||
| Q1 25 | $16.6M | $641.0M | ||
| Q4 24 | $-10.9M | $2.9B | ||
| Q3 24 | $34.0M | $699.0M | ||
| Q2 24 | $23.2M | $768.0M |
自由现金流
ASTH
CCI
| Q1 26 | — | $-43.0M | ||
| Q4 25 | $-6.0M | $2.9B | ||
| Q3 25 | $7.4M | $671.0M | ||
| Q2 25 | $89.5M | $792.0M | ||
| Q1 25 | $13.6M | $601.0M | ||
| Q4 24 | $-13.5M | $2.8B | ||
| Q3 24 | $31.7M | $661.0M | ||
| Q2 24 | $20.4M | $729.0M |
自由现金流率
ASTH
CCI
| Q1 26 | — | -4.3% | ||
| Q4 25 | -0.6% | 268.4% | ||
| Q3 25 | 0.8% | 62.6% | ||
| Q2 25 | 13.7% | 74.7% | ||
| Q1 25 | 2.2% | 56.6% | ||
| Q4 24 | -2.0% | 247.3% | ||
| Q3 24 | 6.6% | 59.0% | ||
| Q2 24 | 4.2% | 65.9% |
资本支出强度
ASTH
CCI
| Q1 26 | — | 14.9% | ||
| Q4 25 | 0.3% | 17.0% | ||
| Q3 25 | 0.3% | 4.0% | ||
| Q2 25 | 0.2% | 3.8% | ||
| Q1 25 | 0.5% | 3.8% | ||
| Q4 24 | 0.4% | 15.7% | ||
| Q3 24 | 0.5% | 3.4% | ||
| Q2 24 | 0.6% | 3.5% |
现金转化率
ASTH
CCI
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 10.40× | ||
| Q3 25 | 26.69× | 2.21× | ||
| Q2 25 | 9.65× | 2.86× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 2.31× | ||
| Q2 24 | 1.21× | 3.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CCI
| Site rental | $961.0M | 95% |
| Services and other | $49.0M | 5% |